"As part of an extension trial published a year later, participants regained an average of two-thirds of the weight they shed within 12 months of discontinuing the drug." Within 12 months of discontinuing the drug, participants regained an average of two-thirds of the weight they shed
Genetic variation in the IGF1 gene may influence how efficiently the biological processes connected to IGF-1 LR3 and Muscle Growth function
Children from the PO+ group showed more pronounced changes in many differential metabolites, affecting all the metabolic classes aforementioned (with the exception of phospholipids and sphingolipids)
Jones TM, Espitia CM, Chipollini J, Lee BR, Wertheim JA, Carew JS, et al
Some data suggests a large portion circulates while bound to carrier proteins, which changes how we look at its pharmacokinetics and distribution